BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10211096)

  • 1. Second cancers in patients with brain tumours--impact of treatment.
    Salminen E; Pukkala E; Teppo L
    Eur J Cancer; 1999 Jan; 35(1):102-5. PubMed ID: 10211096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple primary tumors involving cancer of the brain and central nervous system as the first or subsequent cancer.
    Inskip PD
    Cancer; 2003 Aug; 98(3):562-70. PubMed ID: 12879474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia.
    Brennan P; Coates M; Armstrong B; Colin D; Boffetta P
    Br J Cancer; 2000 Apr; 82(7):1344-7. PubMed ID: 10755412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden.
    Wassberg C; Thörn M; Yuen J; Ringborg U; Hakulinen T
    Br J Cancer; 1996 Jan; 73(2):255-9. PubMed ID: 8546916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second malignant tumors after elective end of therapy for a first cancer in childhood: a multicenter study in Italy.
    Rosso P; Terracini B; Fears TR; Jankovic M; Fossati Bellani F; Arrighini A; Carli M; Cordero di Montezemolo L; Garrè ML; Guazzelli C
    Int J Cancer; 1994 Nov; 59(4):451-6. PubMed ID: 7960210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of second primary cancers, other than melanoma, in an Italian population-based cohort of cutaneous malignant melanoma patients.
    Crocetti E; Carli P
    Eur J Cancer Prev; 2004 Feb; 13(1):33-7. PubMed ID: 15075786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of invasive cancers following squamous cell skin cancer.
    Levi F; Randimbison L; La Vecchia C; Erler G; Te VC
    Am J Epidemiol; 1997 Nov; 146(9):734-9. PubMed ID: 9366621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function?
    Hemminki K; Jiang Y; Steineck G
    Eur J Cancer; 2003 Jan; 39(2):223-9. PubMed ID: 12509955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
    Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
    Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital.
    Swerdlow AJ; Barber JA; Horwich A; Cunningham D; Milan S; Omar RZ
    Br J Cancer; 1997; 75(1):116-23. PubMed ID: 9000608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of second cancers following breast cancer: role of the initial treatment.
    Rubino C; de Vathaire F; Diallo I; Shamsaldin A; Lê MG
    Breast Cancer Res Treat; 2000 Jun; 61(3):183-95. PubMed ID: 10965995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.
    Swerdlow AJ; Douglas AJ; Hudson GV; Hudson BV; Bennett MH; MacLennan KA
    BMJ; 1992 May; 304(6835):1137-43. PubMed ID: 1392790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
    Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
    N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers.
    Levi F; Randimbison L; Te VC; La Vecchia C
    Br J Cancer; 1996 Dec; 74(11):1847-50. PubMed ID: 8956805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of second benign brain tumors among cancer survivors in the surveillance, epidemiology, and end results program.
    Kutsenko A; Berrington de Gonzalez A; Curtis RE; Rajaraman P
    Cancer Causes Control; 2014 Jun; 25(6):659-68. PubMed ID: 24682745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiosarcoma after radiotherapy: a cohort study of 332,163 Finnish cancer patients.
    Virtanen A; Pukkala E; Auvinen A
    Br J Cancer; 2007 Jul; 97(1):115-7. PubMed ID: 17519906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995.
    Milán T; Pukkala E; Verkasalo PK; Kaprio J; Jansén CT; Koskenvuo M; Teppo L
    Int J Cancer; 2000 Jul; 87(2):283-8. PubMed ID: 10861488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of a new primary cancer among patients with lung cancer of different histological types.
    Teppo L; Salminen E; Pukkala E
    Eur J Cancer; 2001 Mar; 37(5):613-9. PubMed ID: 11290437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.